Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Development of mitochondrial gene replacement therapy.

Shaharyar M Khan1, James P Bennett

  • 1Center for the Study of Neurodegenerative Diseases, University of Virginia, Charlottesville, Virginia, USA.

Journal of Bioenergetics and Biomembranes
|September 21, 2004
PubMed
Summary

A new protofection technology enables mitochondrial genome manipulation in living cells. This breakthrough offers potential for treating mitochondrial DNA diseases and understanding complex conditions like Alzheimer's and Parkinson's.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Novel Controlled Metabolic Accelerator for Obesity-Related HFpEF: The HuMAIN-HFpEF Randomized Clinical Trial.

JAMA cardiology·2025
Same author

Making a Case for Adult Orthodontics With Clear Aligner Therapy Provided by the General Dentist.

Compendium of continuing education in dentistry (Jamesburg, N.J. : 1995)·2022
Same author

Mitochondrially-Targeted Therapeutic Strategies for Alzheimer's Disease.

Current Alzheimer research·2021
Same author

Neuroinflammation in Alzheimer's Disease.

Biomedicines·2021
Same author

Energy, Entropy and Quantum Tunneling of Protons and Electrons in Brain Mitochondria: Relation to Mitochondrial Impairment in Aging-Related Human Brain Diseases and Therapeutic Measures.

Biomedicines·2021
Same author

Regulation of neuronal bioenergetics as a therapeutic strategy in neurodegenerative diseases.

Neural regeneration research·2021

Area of Science:

  • Cell Biology
  • Genetics
  • Neuroscience

Background:

  • Mitochondrial DNA (mtDNA) mutations cause classic mitochondrial diseases affecting non-dividing tissues.
  • These diseases often present with varied symptoms, can occur sporadically, and currently lack effective treatments.
  • mtDNA abnormalities are increasingly linked to complex diseases like Alzheimer's, Parkinson's, and type II diabetes, but causal mutations are often undefined.

Purpose of the Study:

  • To develop a method for manipulating the mitochondrial genome to study genotype-phenotype relationships.
  • To enable the development of novel therapeutic strategies for mitochondrial DNA-based diseases.
  • To investigate the role of mtDNA in complex neurological and metabolic disorders.

Main Methods:

  • Development and application of a novel protein transduction technology termed "protofection".

Related Experiment Videos

  • Protofection allows for the insertion and expression of the human mitochondrial genome into mitochondria of living cells.
  • This technology facilitates alteration of the mitochondrial genotype and introduction of exogenous genes.

    • Main Results:

    • Protofection successfully enables the manipulation of the mitochondrial genotype within living cells.
    • Exogenous genes can be introduced and targeted to mitochondria or other cellular compartments.
    • The technology demonstrates in vivo delivery of mtDNA, paving the way for gene therapy.

    Conclusions:

    • Protofection is a groundbreaking technology for altering the mitochondrial genome in living cells.
    • This method holds significant promise for advancing research into mitochondrial DNA diseases and complex associated disorders.
    • Protofection opens new avenues for developing mitochondrial gene replacement therapies.